Table 1 Patient demographic characteristics by diagnosis

From: Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador

Characteristic

ALL

AML

Age in years, median (range)

5.2 (0.0, 15.1)

5.5 (0.2, 15.7)

Male, N (%)

263 (56)

40 (51)

Initial WBC (109l−1) median (IQR)

11.5 (4.5, 36.3)

15.8 (6.7, 56.6)

Initial haemoglobin (g l−1), median (IQR)

69 (51, 90)

77 (50, 97)

Immunophenotype, no (%)

 B lineage

421 (92)

 

 T lineage

35 (8)

 

FAB classification, N (%)

 M0

 

7 (9)

 M1

 

18 (24)

 M2

 

26 (34)

 M4

 

8 (11)

 M5

 

6 (8)

 M6

 

2 (3)

 M7

 

7 (9)

Risk group, N (%)

 Higher risk

194 (44)

 

 Standard riska

250 (56)

 

Parental education, N (%)

 Illiterate

17 (4)

3 (4)

 Primary

290 (63)

51 (67)

 Secondary

107 (23)

18 (24)

 Advanced

41 (9)

3 (4)

 Unknown

4 (1)

1 (1)

Hours to travel to clinic, median (IQR)

2.0 (1.0, 3.0)

2.0 (1.0, 3.0)

Monthly household income (dollars), median (IQR)

150 (100, 250)

150 (57, 228)

Body mass index percentile, median (IQR)

43.2 (11.1, 81.3)

41.2 (10.7, 77.8)

Triceps skin-fold thickness percentile, median (IQR)

17.5 (2.5, 62.5)

37.5 (17.5, 62.5)

Mid-upper arm circumference percentile, median (IQR)

17.5 (2.5, 37.5)

17.5 (2.5, 37.5)

  1. Abbreviations: ALL=acute lymphoblastic leukaemia; AML=acute myeloid leukaemia; FAB=French-American-British; IQR=interquartile range; N, number; WBC, white blood cell count; .
  2. aStandard risk was defined as DNA index 1.16, WBC <50 × 109/l, age >12 months and <10 years, without any of the following: (1) T-cell lineage, (2) CNS leukaemia at diagnosis, (3) testicular leukaemia or (4) bone marrow M3 on day 15 or M2-M3 on day 36.